skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Victor M. Rivera, M.D.

Distinguished Emeritus Professor of Neurology

Founding Director, Maxine Mesinger MS Comprehensive Care Center

Clinical Service Area

Neurology

Specialty

Multiple Sclerosis
Optic Neuritis
Demyelinating Diseases

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments

713-798-7707

Consult

713-798-7707

Medical School

M.D., Universidad Nacional Autonoma, Mexico City, Mexico

Internship

Internal Medicine, Manchester Memorial Hospital, Manchester, Conn.

Residency

Neurology, Baylor College of Medicine, Houston, Texas

Clinic Location

Maxine Mesinger MS Comprehensive Care Center
Neurosensory Building
6501 Fannin, NB100
Houston, Texas 77030

Clinical Interests

Multiple sclerosis and demyelinating diseases, cerebral and spinal vascular disorders, general neurology

Contact Information

Victor M. Rivera, M.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-2273
Fax: 713-798-6273
Email:

BCM Honors

  • 2010 Fulbright & Jaworski LLP Faculty Excellence Award for Teaching and Evaluation and has become a member of the Academy of Distinguished Educators, which recognizes the educational scholarship of faculty members involved in all of the educational missions of Baylor College of Medicine.

Journal Publications (Selected out of 83)

  • Macias-Islas MA, Soria-Cedillo IF, Velazquez-Quintana M, Rivera VM, Baca-Muro VI, Lemus-Carmona EA, et al. Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis. Acta Neurol Belg. 2013;113(4):415-20. [View journal article]
  • Rivera VM, Jeffery DR, Weinstock-Guttman B, Bock D, Dangond F. Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study. BMC Neurol. 2013;13(1):80. [View journal article]
  • Rivera VM. Tovaxin for multiple sclerosis. Expert Opin Biol Ther. 2011;11(7):961-7. [View journal article]
  • Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera V. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology. 2011;77(5):505-7. [View journal article]
  • Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al. Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. Ther Adv Neurol Disord. 2011;4(1):3-14. [View journal article]
  • Cohen BA, Rivera VM. PRISMS: the story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin. 2010;26(4):827-38. [View journal article]
  • Rivera VM. The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology. 2010;74(10):864. [View journal article]
  • Rivera VM. Multiple Sclerosis in Latin America. Reality and Challenge. Neuroepidemiology. 2009;32(4):294-295. [View journal article]
  • Cristiano E, Arcega R, Correale J, Gabbay AA, Lander-Delgado R, Macias-Islas MA, et al. [Recommendations for optimising the treatment of multiple sclerosis in Latin America]. Rev Neurol. 2007;44(8):494-8. [View journal article]
  • Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg. 2007;109(1):102-5. [View journal article]

Poster and Platform Presentations (Selected out of 44)

  • Stosic M, De Jesus P, McCarthy J, Hutton GJ, Rivera VM. Multiple sclerosis patient treated with natalizumab develops immune thrombocytopenic purpura. Presented at the Baylor College of Medicine (BCM), Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012). [View poster]
  • Avila M, Prieto P, Avila-Ornelas J, Stosic M, Amin A, Hutton GJ, et al. Distal limb discoloration in patients with multiple sclerosis - Case series of 41 patients. Neurology. 2011;76(Suppl 4):A290. [View poster]
  • Avila J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, et al. The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Avila M, Hutton G, Rivera VM. Recurrent and multiphasic disseminated encephalomyelitis, case series. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Avila M, Prieto P, Robles L, Stosic M, Avila J, Hutton G, et al. Sleep disorders in multiple sclerosis. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Avila M, Prieto P, Robles L, Avila J, Stosic M, Hutton G, et al. Distal lower limb discoloration in patients with multiple sclerosis. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Robles L, Hutton GJ, Rivera VM. Use of natalizumab in Hispanic patients with relapsing remitting multiple sclerosis. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Thorne BJ, Perez FI, Rivera VM, Hutton GJ. Computer-assisted cognitive rehabilitation for multiple sclerosis — Updated findings. Presented at the Consortium of Multiple Sclerosis Centers (CMSC), 24th Annual Meeting in San Antonio, Texas (June 2-5, 2010). [View poster]
  • Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al. Associations between annualized relapse rate and long-term exposure to subcutaneous interferon beta-1a in the Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study. Presented at the European Neurological Society (ENS), 20th Annual Meeting in Berlin, Germany (June 19-23, 2010). [View poster]
  • Hutton G, Avila M, Prieto PG, Avila J, Rivera V. Multiple sclerosis and other CNS demyelination after treatment with tumor necrosis factor alpha blockers. Neurology. 2010;74(9 Suppl 2):A371. [View poster]

E-mail this page to a friend